financetom
Market
financetom
/
Market
/
Texas Capital Bancshares Will Be Impacted By Fed's Rate Move, Says Analyst
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas Capital Bancshares Will Be Impacted By Fed's Rate Move, Says Analyst
Apr 1, 2024 9:24 AM

Texas Capital Bancshares Inc ( TCBI ) shares were down in early trading on Monday.

The Federal Reserve is likely to cut its benchmark interest rates three times by 25 basis points (bps) each in 2024, beginning in June, and by three more times by 25bps in 2025, according to Truist Securities.

The Texas Capital Bancshares ( TCBI ) Analyst: Brandon King downgraded the rating for Texas Capital Bancshares ( TCBI ) from Buy to Hold, while slashing the price target from $72 to $66.

The Texas Capital Bancshares Thesis: Net interest income (NII) is likely to continue exerting pressure on results "from lower mortgage yields and continued deposit pricing pressures," King said in the downgrade note.

Check out other analyst stock ratings.

"While we think a slower Fed easing cycle should provide some benefit to more asset sensitive names, we expect deposit betas on the downside to be relatively less than they were on the upside, offsetting less pressure on earning asset yields, and drives our NII estimates lower by a median of 1% in 2024 and 2025," the analyst wrote.

"Most bank management teams are anticipating an acceleration in loan growth sometime later this year, which will likely limit aggressive deposit repricing as retention becomes more important for funding efforts," he added.

"Our 2024/2025 EPS estimates are 12%/13% below consensus and our 2024/2025 NII estimates are $849m/$878m vs. consensus at $908m/$962m," King further stated.

TCBI Price Action: Shares of Texas Capital Bancshares ( TCBI ) had declined by 2.17% to $60.22 at the time of publication on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech Stocks Mixed Tuesday Afternoon
Sector Update: Tech Stocks Mixed Tuesday Afternoon
Mar 19, 2024
02:01 PM EDT, 03/19/2024 (MT Newswires) -- Tech stocks were mixed Tuesday afternoon, with the Technology Select Sector SPDR Fund (XLK) rising 0.4% and the SPDR S&P Semiconductor ETF (XSD) shedding 0.5%. The Philadelphia Semiconductor Index fell 0.8%. In corporate news, Microsoft ( MSFT ) shares added 0.7% after the tech giant said Tuesday it hired Mustafa Suleyman and Karen...
Sector Update: Energy Stocks Rise in Tuesday Afternoon Trading
Sector Update: Energy Stocks Rise in Tuesday Afternoon Trading
Mar 19, 2024
02:00 PM EDT, 03/19/2024 (MT Newswires) -- Energy stocks were higher Tuesday afternoon, with the NYSE Energy Sector Index and the Energy Select Sector SPDR Fund (XLE) each rising 1%. The Philadelphia Oil Service Sector index climbed 1.8%, and the Dow Jones US Utilities index was up 0.5%. Front-month West Texas Intermediate crude oil was rising 1.3% to $83.77 a...
Equity Markets Rise Intraday as Fed Meeting Begins
Equity Markets Rise Intraday as Fed Meeting Begins
Mar 19, 2024
02:04 PM EDT, 03/19/2024 (MT Newswires) -- US benchmark equity indexes were higher intraday as the Federal Reserve kicked off its two-day monetary policy meeting. The Dow Jones Industrial Average was up 0.6% at 39,017.43 after midday Tuesday, while the S&P 500 rose 0.3% to 5,165.9. The Nasdaq Composite advanced 0.3% to 16,145.2. Among sectors, energy led the gainers. Communication...
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
Mar 19, 2024
02:04 PM EDT, 03/19/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon with the NYSE Health Care Index gaining 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%. The iShares Biotechnology ETF (IBB) advanced 0.6%. In corporate news, AstraZeneca ( AZN ) agreed to buy Fusion Pharmaceuticals ( FUSN ) for as much as $2.4 billion....
Copyright 2023-2025 - www.financetom.com All Rights Reserved